Dr. Mani Kalantari Nezhad, MD

Dr. Nezhad practices at Dignity Health - St. John's Regional Medical Center in Oxnard, California, part of CommonSpirit Health.

Dr. Nezhad's NPI, 1669716387, was assigned on November 19, 2012. Dr. Nezhad graduated from Georgetown University School Of Medicine in 2011. Dr. Nezhad holds California license A123630.

Dr. Nezhad's primary practice is Dignity Health - St. John's Regional Medical Center, at 1600 N Rose Ave, Oxnard, CA 93030 in Ventura County. The practice phone is (805) 988-2500.

Dr. Nezhad's primary practice is Dignity Health - St. John's Regional Medical Center in Oxnard, California, part of CommonSpirit Health. Dr. Nezhad is also affiliated with Dignity Health - Marian Regional Medical Center. The medical group on file is Link Integrated Healthcare. Dmand AI also links Dr. Nezhad to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nezhad practices, 8 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Nezhad's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Nezhad is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Nezhad is licensed in California.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, epilepsy, head injury, hereditary polyneuropathy and lower back pain among the conditions Dr. Nezhad treats.

CMS data shows 1,939 Medicare services from Dr. Nezhad across 14 procedure codes in 2024, for 642 Medicare patients. Medicare paid $190,415 for them.

CMS counts 642 Medicare patients who saw Dr. Nezhad in 2024. The largest group is 75 to 84, with 251 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nezhad's median patient age at 69, with 56% women.

In 2024, Dr. Nezhad wrote 1,039 Medicare Part D claims for 214 patients. 86% of them were for generic drugs. CMS names the drug for 805 of them, across 22 drugs with 11 or more claims each, at $847,498 in total drug cost. In 2023, CMS named 855 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Nezhad for performance year 2024, reported through an alternative payment model (APM). Dr. Nezhad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Nezhad, published from 2012 to 2020. The most frequent topics are Bone Plates, Fracture Fixation, Internal and Fractures, Bone. Dr. Nezhad's most frequent co-authors are Scott Edwards, MD, Allen M. Ferrucci, MD and Patrick Donovan Lyden, MD.

CMS Open Payments shows 150 general payments to Dr. Nezhad from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $1,083.

Dr. Nezhad graduated from Georgetown University School Of Medicine in 2011. Dr. Nezhad is a member of AAN and AHA.

Dr. Nezhad is in network with 12 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.